An involvement of NF-κB in ALS is further supported by the evidence that pharmacological inhibition of this pathway conferred beneficial effects in mouse models of ALS, including attenuation of TDP-43 pathology in motor neurons (Swarup et al., 2011b; Dutta et al., 2017). Here, NFKB1 is linked to amyotrophic lateral sclerosis.